Antioxidant

Phase 3Small molecule

UUnity Health Toronto

Antioxidant is one of 87 small molecule programs targeting Ischemia. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

IschemiaActive, not recruiting

Oral Submucous FibrosisActive, not recruiting

COVID-19Active, not recruiting

Type 1 DiabetesActive, not recruiting

IschemiaPhase 3

Active, not recruiting

Oral Submucous FibrosisPhase 3

Active, not recruiting

COVID-19Phase 3

Active, not recruiting

Type 1 DiabetesPhase 3

Active, not recruiting

Competition

Competitive Landscape

1931 competitors in COVID-19

#DrugCompanyPhaseTrials

Antioxidant

UUnity Health Toronto

Phase 3

1 2

Spikevax

Moderna

Preclinical

21 3

COVID-19 Vaccine

Moderna

Preclinical

27 4

Aimovig

Amgen

Preclinical

1 5

Aldactone

Pfizer

Preclinical

1 6

Nexavar

Bayer

Preclinical

1 7

Activella

Eli Lilly

Preclinical

—8

Aquasol E

NNational Eye Institute (NEI)

Preclinical

1 9

Tricor

JJagotec

Preclinical

1 10

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Ischemia1 trial

The DIEP Flap as a Model of Ischemia-Reperfusion: an Intervention Study

Unknown status·MMaastricht University Medical Center·Phase 3·NCT00821158·30 enrolled

COVID-191 trial

Canadian Adaptive Platform Trial of Treatments for COVID-19 in Community Settings

Active, not recruiting·UUnity Health Toronto·Phase 3·NCT05614349·797 enrolled

Oral Submucous Fibrosis1 trial

Evaluation of Efficacy of Aloevera in the Treatment of Oral Submucous Fibrosis- A Clinical Study

Completed·TThe Oxford Dental College, Hospital and Research Center, Bangalore, India·Phase 3·NCT02714543·74 enrolled

Type 1 Diabetes1 trial

An Intervention Trial for Cardiac Neuropathy in Type 1 Diabetes

Completed·UUniversity of Michigan·Phase 3·NCT00116207·44 enrolled

Clinical Trial1 trial

The Effect of an Antioxidant Gel Compared to Chlorhexidine Gel During the Soft Tissue Healing Process: A Randomized Controlled Clinical Trial

Active, not recruiting·KKuwait University·Phase 4·NCT06894667·40 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for Antioxidant. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Antioxidant compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Antioxidant. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Unity Health Toronto company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: UUnity Health Toronto

Antioxidant

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Ischemia1 trial

COVID-191 trial

Oral Submucous Fibrosis1 trial

Type 1 Diabetes1 trial

Clinical Trial1 trial

References

Drug Info

Quick Facts

Related News